Literature DB >> 3121560

Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.

H Kato1, Y Suehiro, H Morioka, T Torigoe, A Myoga, K Sekiguchi, I Ikeda.   

Abstract

Tumor antigen TA-4 is divided into two subgroups; acidic and neutral TA-4. The tissue localizations of these TA-4 subgroups were examined by using monoclonal antibodies, i.e., Mab-21 which reacts with both acidic and neutral TA-4, and Mab-317 which is specific to acidic TA-4. Immunohistochemical staining with Mab-21 showed positive cells in most parts of the cancer nest and in the intermediate layer of the non-cancerous squamous epithelium of the uterine cervix, whereas positive staining with Mab-317 was observed only in the cells at the peripheral parts of the cancer nest adjacent to the surrounding stromal tissue. Thus, examination of the subgroups of TA-4 may be a useful aid for investigating the biologic behavior of squamous cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121560

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  5 in total

1.  Serum squamous cell carcinoma antigen levels in women with neoplasms of the lower genital tract and in healthy controls.

Authors:  W Neunteufel; G Tatra; C Bieglmayer
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Inhibition of Staphylococcus aureus cysteine proteases by human serpin potentially limits staphylococcal virulence.

Authors:  Tomasz Kantyka; Karolina Plaza; Joanna Koziel; Danuta Florczyk; Hennig R Stennicke; Ida B Thogersen; Jan J Enghild; Gary A Silverman; Stephen C Pak; Jan Potempa
Journal:  Biol Chem       Date:  2011-05       Impact factor: 3.915

3.  Protein expression profile using two-dimensional gel analysis in squamous cervical cancer patients.

Authors:  Su-Mi Bae; Hyun-Jin Min; Guo Hua Ding; Sun-Young Kwak; Young-Lae Cho; Kye-Hyun Nam; Choong Hak Park; Yong-Wan Kim; Chong-Kook Kim; Byoung-Don Han; Young-Joo Lee; Do Kang Kim; Woong-Shick Ahn
Journal:  Cancer Res Treat       Date:  2006-04-30       Impact factor: 4.679

4.  IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.

Authors:  Alessandra Biasiolo; Natascia Tono; Mariagrazia Ruvoletto; Santina Quarta; Cristian Turato; Gianmarco Villano; Luca Beneduce; Giorgio Fassina; Carlo Merkel; Angelo Gatta; Patrizia Pontisso
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

5.  Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell death.

Authors:  Pieter J A de Koning; J Alain Kummer; Stefanie A H de Poot; Razi Quadir; Roel Broekhuizen; Anne F McGettrick; Wayne J Higgins; Bart Devreese; D Margaret Worrall; Niels Bovenschen
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.